Antiretroviral therapy prior to acute viral replication preserves CD4 T cells in the periphery but not in rectal mucosa during acute simian immunodeficiency virus infection.
about
Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategiesUsing nonhuman primates to model HIV transmissionA tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessationAccelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixaforCD4 T cell subsets in the mucosa are CD28+Ki-67-HLA-DR-CD69+ but show differential infection based on alpha4beta7 receptor expression during acute SIV infection.Extralymphoid CD8+ T cells resident in tissue from simian immunodeficiency virus SIVmac239{Delta}nef-vaccinated macaques suppress SIVmac239 replication ex vivo.Persistence of genital tract T cell responses in HIV-infected women on highly active antiretroviral therapy.Loss and dysregulation of Th17 cells during HIV infection.Rhesus macaque lymph node PD-1(hi)CD4+ T cells express high levels of CXCR5 and IL-21 and display a CCR7(lo)ICOS+Bcl6+ T-follicular helper (Tfh) cell phenotype.A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8(+)FoxP3(+) T cells in simian immunodeficiency virus-infected controller rhesus macaques.Suppression of transforming growth factor β receptor 2 and Smad5 is associated with high levels of microRNA miR-155 in the oral mucosa during chronic simian immunodeficiency virus infection.Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxisSuppressed Th17 levels correlate with elevated PIAS3, SHP2, and SOCS3 expression in CD4 T cells during acute simian immunodeficiency virus infection.A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system.Significant Depletion of CD4(+) T Cells Occurs in the Oral Mucosa during Simian Immunodeficiency Virus Infection with the Infected CD4(+) T Cell Reservoir Continuing to Persist in the Oral Mucosa during Antiretroviral Therapy.Early treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection.
P2860
Q26825814-86B8F54B-4308-4725-973E-B7037D36738DQ26861425-687AE26B-BD75-47DD-9D4B-59AA5849E89AQ27319650-11F78E07-2506-48C1-8468-98B3C3EAB8B9Q28742157-2E71D4BC-D695-458B-AE40-5FE83FA2409EQ33619083-DE671EE7-B856-4027-A1BF-0C1297B99183Q33725546-ABEC4C78-DF0C-4449-9FB6-69D17DFC6D59Q34178412-E3AF7A0F-71BB-4481-8704-EDABF6C8E354Q34350569-5BEB198B-C813-4AF7-8EF2-C64CF3812C61Q34635510-7D83A9C7-9408-45D9-9CC4-1E2748668A05Q34990151-4F7EFF12-A76F-4A99-9A3A-89C5D8C95743Q35069126-1ADFD71E-797A-4155-8D20-67A4938F4515Q35076724-C3DCD3E0-AF7D-4ECB-9A9D-703CC1D67FD3Q36379277-D2C10C44-F5A8-4BC1-B6C7-73F60935660FQ36911659-653085F1-6B2F-441C-922D-08F5E0A9A6DAQ37829628-4670AA18-2F3A-4486-8CAC-91E6FA457713Q40639388-2B51C63E-303C-4FD9-ACEC-CD429759605EQ47551858-9BE1BC45-801B-474E-B6F0-3A9F108030FC
P2860
Antiretroviral therapy prior to acute viral replication preserves CD4 T cells in the periphery but not in rectal mucosa during acute simian immunodeficiency virus infection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Antiretroviral therapy prior t ...... unodeficiency virus infection.
@en
type
label
Antiretroviral therapy prior t ...... unodeficiency virus infection.
@en
prefLabel
Antiretroviral therapy prior t ...... unodeficiency virus infection.
@en
P2093
P2860
P356
P1433
P1476
Antiretroviral therapy prior t ...... unodeficiency virus infection.
@en
P2093
Jeffrey D Lifson
Mario Roederer
Matthew Eberly
Michael Piatak
Muhamuda Kader
P2860
P304
11467-11471
P356
10.1128/JVI.01143-08
P407
P577
2008-09-03T00:00:00Z